A5006604726- Viral Infections and Immunology Research
- Viral gastroenteritis research and epidemiology
- Animal Disease Management and Epidemiology
- Vaccine Coverage and Hesitancy
- SARS-CoV-2 detection and testing
- Viral Infections and Vectors
- Respiratory viral infections research
- Hepatitis B Virus Studies
- COVID-19 Clinical Research Studies
- Migration, Health and Trauma
- SARS-CoV-2 and COVID-19 Research
- Malaria Research and Control
- Pneumonia and Respiratory Infections
- Bacterial Identification and Susceptibility Testing
- Hepatitis Viruses Studies and Epidemiology
- Hepatitis C virus research
- Influenza Virus Research Studies
- Mosquito-borne diseases and control
- Diphtheria, Corynebacterium, and Tetanus
- Clostridium difficile and Clostridium perfringens research
- Whipple's Disease and Interleukins
- Cervical Cancer and HPV Research
Chitwan Medical College
2020
World Health Organization Regional Office for the Western Pacific
2016-2019
Ministry of Health and Population
2019
Background: This study assessed human papillomavirus (HPV), cervical cancer, and HPV vaccine knowledge awareness among women in two sub-populations Nepal - Khokana, a traditional Newari village the Lalitpur District about eight kilometers south of Kathmandu, Sanphebagar, development committee within Achham rural Far-Western Nepal. Methods: Study participants were recruited during health camps conducted by Fertility Care Center, Nepali non-governmental organization. Experienced staff...
The World Health Organization (WHO) Western Pacific Region (WPR) has maintained its polio-free status since 2000. emergence of vaccine-derived polioviruses (VDPVs), however, remains a risk, as oral polio vaccine (OPV) is still used in many the region’s countries, and pockets unimmunized or underimmunized children exist some countries. From 2014 to 2016, region participated globally coordinated efforts introduce inactivated (IPV) into all countries that did not yet include it their national...
Since 1988, when World Health Organization (WHO) Member States and partners launched the Global Polio Eradication Initiative, number of wild poliovirus (WPV) cases has declined from 350,000 in 125 countries to 176 only two 2019 (1). The Commission for Certification Poliomyelitis (GCC) declared three WPV types, type 2 (WPV2) 3 (WPV3), eradicated globally 2015 2019, respectively Wild 1 (WPV1) remains endemic Afghanistan Pakistan Containment under strict biorisk management measures is vital...
Among the three wild poliovirus (WPV) types, type 2 (WPV2) was declared eradicated globally by Global Commission for Certification of Poliomyelitis Eradication (GCC) in 2015. Subsequently, 2016, a global withdrawal Sabin oral vaccine (OPV2) from routine use, through synchronized switch trivalent formulation (tOPV, containing virus types 1, 2, and 3) to bivalent form (bOPV, 1 3), implemented. WPV 3 (WPV3), last detected 2012 (1), will possibly be late 2019.* To ensure that polioviruses are...
The live attenuated Japanese encephalitis (JE) vaccine SA14-14-2 has been used in Nepal for catch-up campaigns and is now included the routine immunisation schedule. Previous studies have shown good efficacy after one dose districts with a high incidence of JE. first well-documented dengue outbreak occurred 2006 ongoing cases thought to be secondary migration from India. infection virus (DENV) partially protects against JE might also influence serum neutralising antibody titres JEV. This...
Many countries have weak disease surveillance and immunization systems. The elimination of polio creates an opportunity to use staff assets from the eradication programme control other vaccine-preventable diseases improve systems.In 2003, active system Nepal's began report on measles neonatal tetanus cases. Japanese encephalitis rubella cases were added in 2004. Staff aided development implementation government policies, helped launch vaccination campaigns, trained reporting practices...
During the 26th Technical Advisory Group (TAG) meeting in Manila July 2017, recommendation was made to WHO Secretariat conduct a survey map diphtheria laboratory capacity region and gather information on diagnostic testing methods. The gap analysis carried out with structured questionnaires; conducted 18 bacteriological laboratories including 15 countries Region, responses received from 17 14 countries.
Recurrent or persistent positivity of SARS-CoV-2 RNA in clinically recovered COVID-19 patients have been reported worldwide. However, replication competent live viruses were not beyond two to three weeks from onset symptoms mild severe cases COVID-19. End stage renal disease is characterized by uremia induced immune dysfunction that increases the risk infectious diseases including The clinical implications recurrent persistently positive immunocompromised are difficult be generalized...